全球無創產前檢測 (NIPT) 市場

到 2030 年，全球無創產前檢測 (NIPT) 市場規模將達到 92 億美元

2024 年全球非侵入性產前檢測 (NIPT) 市場規模估計為 49 億美元，預計到 2030 年將達到 92 億美元，2024-2030 年分析期內的複合年成長率為 10.9%。 NIPT 耗材和試劑是報告分析的細分市場之一，預計複合年成長率為 8.5%，到分析期結束時將達到 55 億美元。在分析期內，NIPT 設備部分預計將以 15.2% 的複合年成長率成長。

美國市場規模估計為 13 億美元，中國市場預計複合年成長率為 14.0%

預計 2024 年美國無創產前檢測 (NIPT) 市值將達 13 億美元。中國是世界第二大經濟體，預計到 2030 年市場規模將達到 21 億美元，2024-2030 年分析期間的複合年成長率為 14.0%。其他值得注意的區域市場包括日本和加拿大，預計在分析期間的複合年成長率分別為 7.7% 和 8.7%。在歐洲，預計德國的複合年成長率約為 8.2%。

全球無創產前檢測 (NIPT) 市場 - 主要趨勢和促進因素摘要

為什麼非侵入性產前檢測（NIPT）會出現在產婦照護領域？

非侵入性產前檢測（NIPT）為孕婦提供了一種更安全、更準確的方法來檢測胎兒的染色體異常，從而迅速改變了產前護理。 NIPT 分析母親血液中存在的無細胞胎兒 DNA，以識別唐氏症、愛德華氏症候群和帕陶氏症候群等遺傳疾病。與羊膜穿刺術和絨毛膜絨毛取樣等有流產風險的傳統侵入性手術不同，NIPT 可提供可靠的結果且風險最小。此檢查通常在懷孕初期進行，適用於高風險妊娠，以便儘早做出決策並更好地進行產婦護理管理。隨著人們對基因篩檢認知的提高，NIPT 正在成為常規產前篩檢的重要組成部分。

NIPT 市場的關鍵部分有哪些？

關鍵技術包括次世代定序儀（NGS）、微陣列和聚合酵素鏈鎖反應（PCR），其中以NGS應用最為廣泛，因為它可以同時高精度地檢測多個遺傳標記。在應用方面，NIPT主要用於檢測唐氏症（21三體症）、愛德華氏症候群（18三體症）、帕陶氏症候群（13三體症）等三體症。其他應用包括檢測性染色體異常和微缺失。 NIPT的主要終端使用者是醫院、診斷實驗室和產科診所，基因檢測正在成為產前護理的標準組成部分，尤其是對於35歲以上的女性和有遺傳病史的女性。

NIPT 如何融入產前護理和診斷？

醫院和產科診所正在將 NIPT 作為高風險懷孕常規產前篩檢的一部分，早期發現染色體異常對於醫療決策至關重要。診斷實驗室使用 NIPT 提供全面的基因篩檢服務，通常與醫療保健提供者合作以確保及時獲得結果和後續護理。研究機構正在探索 NIPT 除了染色體異常之外的潛力，例如篩檢單基因疾病和更廣泛的遺傳學見解。此外，遠端醫療服務促進了遠距諮詢和 NIPT 的獲取，使得服務不足地區的孕婦更容易獲得 NIPT。醫療保健提供者和孕婦對 NIPT 的認知和接受度不斷提高，支持了其在當代產前護理中發揮的作用。

哪些因素推動了非侵入性產前檢測（NIPT）市場的成長？

非侵入性產前檢測（NIPT）市場的成長受到多種因素的推動，包括對早期和準確的產前篩檢的需求不斷成長，尤其是在高風險妊娠中。次世代定序和其他基因分析技術的進步使得 NIPT 更加準確、高效、經濟實惠且易於取得。人們對遺傳疾病的認知不斷提高以及早期檢測的好處也促進了 NIPT 的廣泛應用。多個國家對 NIPT 的監管核准，加上政府對產婦保健的支持，進一步推動了市場的成長。此外，遠端醫療服務和直接面對消費者的測試模式的擴展使 NIPT 更加容易獲得，加速了其在世界各地孕婦中的應用。

部分

產品（消耗品/試劑、設備）；方法（母體血漿中的無細胞 DNA 檢測、超音波檢測、生化篩檢測試）；應用（三體性、微缺失症候群、其他應用）；最終用途（診斷實驗室、醫院）

受訪公司範例（總合33家）

• Agilent Technologies, Inc.
• Berry Genetics Inc.
• BGI Genomics Co. Ltd.
• Eurofins LifeCodexx GmbH
• F. Hoffmann-La Roche Ltd.
• GE Healthcare
• Igenomix
• Illumina, Inc.
• Laboratory Corporation of America Holdings
• Natera, Inc.
• PerkinElmer Inc.
• Thermo Fisher Scientific Inc.
• Yourgene Health

目錄

第1章調查方法

第 2 章執行摘要

• 市場概況
• 主要企業
• 市場趨勢和促進因素
• 全球市場展望

第3章 市場分析

• 美國
• 加拿大
• 日本
• 中國
• 歐洲
• 法國
• 德國
• 義大利
• 英國
• 西班牙
• 俄羅斯
• 其他歐洲國家
• 亞太地區
• 澳洲
• 印度
• 韓國
• 其他亞太地區
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲國家
• 中東
• 伊朗
• 以色列
• 沙烏地阿拉伯
• 阿拉伯聯合大公國
• 其他中東地區
• 非洲

第4章 競賽

Global Non-Invasive Prenatal Testing (NIPT) Market to Reach US$9.2 Billion by 2030

The global market for Non-Invasive Prenatal Testing (NIPT) estimated at US$4.9 Billion in the year 2024, is expected to reach US$9.2 Billion by 2030, growing at a CAGR of 10.9% over the analysis period 2024-2030. NIPT Consumables & Reagents, one of the segments analyzed in the report, is expected to record a 8.5% CAGR and reach US$5.5 Billion by the end of the analysis period. Growth in the NIPT Instruments segment is estimated at 15.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.3 Billion While China is Forecast to Grow at 14.0% CAGR

The Non-Invasive Prenatal Testing (NIPT) market in the U.S. is estimated at US$1.3 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$2.1 Billion by the year 2030 trailing a CAGR of 14.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.7% and 8.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 8.2% CAGR.

Global Non-Invasive Prenatal Testing (NIPT) Market - Key Trends and Drivers Summarized

Why Is Non-Invasive Prenatal Testing (NIPT) Gaining Ground in Prenatal Care?

Non-Invasive Prenatal Testing (NIPT) is rapidly transforming prenatal care by offering expectant parents a safer and more accurate method for detecting chromosomal abnormalities in the fetus. NIPT analyzes cell-free fetal DNA present in the mother’s blood to identify genetic conditions like Down syndrome, Edwards syndrome, and Patau syndrome. Unlike traditional invasive procedures like amniocentesis or chorionic villus sampling, which carry risks of miscarriage, NIPT provides reliable results with minimal risk. The test is typically performed during the first trimester and is suitable for high-risk pregnancies, enabling early decision-making and better management of prenatal care. As awareness of genetic screening increases, NIPT is becoming an integral part of routine prenatal screening.

What Are the Key Segments in the NIPT Market?

Key technologies include next-generation sequencing (NGS), microarray, and polymerase chain reaction (PCR), with NGS being the most widely used due to its high accuracy and ability to detect multiple genetic markers simultaneously. In terms of application, NIPT is primarily used for detecting trisomies, including Down syndrome (trisomy 21), Edwards syndrome (trisomy 18), and Patau syndrome (trisomy 13). Other applications include detecting sex chromosome abnormalities and microdeletions. The major end-users of NIPT include hospitals, diagnostic laboratories, and maternity clinics, where genetic testing is becoming a standard component of prenatal care, particularly for women over 35 or those with a history of genetic disorders.

How Is NIPT Integrated Across Prenatal Care and Diagnostics?

Hospitals and maternity clinics are incorporating NIPT as part of routine prenatal screening for high-risk pregnancies, where early detection of chromosomal abnormalities is crucial for medical decision-making. Diagnostic laboratories use NIPT to offer comprehensive genetic screening services, often in collaboration with healthcare providers to ensure timely results and follow-up care. Research institutions are exploring the potential of NIPT beyond chromosomal abnormalities, including screening for single-gene disorders and broader genetic insights. Additionally, telehealth services are facilitating remote consultations and access to NIPT, making it more accessible to pregnant women in underserved regions. The growing awareness and acceptance of NIPT among healthcare providers and expectant parents underscore its role in modern prenatal care.

What Factors Are Driving the Growth in the Non-Invasive Prenatal Testing (NIPT) Market?

The growth in the Non-Invasive Prenatal Testing (NIPT) market is driven by several factors, including the increasing demand for early and accurate prenatal screening, particularly in high-risk pregnancies. Advances in next-generation sequencing and other genetic analysis technologies have improved the accuracy, efficiency, and affordability of NIPT, making it more accessible. The rising awareness of genetic disorders and the benefits of early detection have also contributed to the broader adoption of NIPT. Regulatory approvals for NIPT in several countries, combined with government support for maternal healthcare, have further fueled market growth. Additionally, the expansion of telehealth services and direct-to-consumer testing models has made NIPT more accessible, increasing its adoption among expectant mothers worldwide.

SCOPE OF STUDY:

The report analyzes the Non-Invasive Prenatal Testing (NIPT) market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Consumables & Reagents, Instruments); Method (Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection, Biochemical Screening Tests); Application (Trisomy, Microdeletion Syndrome, Other Applications); End-Use (Diagnostic Laboratories, Hospitals)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 33 Featured) -

• Agilent Technologies, Inc.
• Berry Genetics Inc.
• BGI Genomics Co. Ltd.
• Eurofins LifeCodexx GmbH
• F. Hoffmann-La Roche Ltd.
• GE Healthcare
• Igenomix
• Illumina, Inc.
• Laboratory Corporation of America Holdings
• Natera, Inc.
• PerkinElmer Inc.
• Thermo Fisher Scientific Inc.
• Yourgene Health

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Global Economic Update
  • Non-Invasive Prenatal Testing (NIPT) - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Demand for Early and Accurate Fetal Screening Spurs Growth in Non-Invasive Prenatal Testing Market
  • Technological Advancements in Cell-Free DNA Sequencing and Genomic Analysis Strengthen Business Case for Adoption
  • Growing Focus on Early Detection of Genetic Abnormalities Expands Addressable Market
  • Expansion of NIPT in Hospital Laboratories, Diagnostic Centers, and Clinics Fuels Market Growth
  • Increasing Adoption of NIPT in Routine Prenatal Care and Risk Assessment Expands Market Opportunities
  • Technological Innovations in Multi-Gene Panels and Whole Genome Sequencing Propel Market Expansion
  • Rising Focus on Reducing Invasive Testing Procedures and Pregnancy Risks Drives Demand for NIPT
  • Growing Use of NIPT in High-Risk Pregnancies, Advanced Maternal Age, and IVF Monitoring Expands Market Potential
  • Technological Advancements in AI-Powered Genomic Interpretation and Report Automation Propel Market Growth
  • Increasing Focus on Integrating NIPT with Digital Health Platforms and Telemedicine Drives Adoption
  • Rising Demand for NIPT in Personalized Maternal Care and Fetal Health Management Strengthens Global Market
  • Expansion of NIPT in Screening for Rare Diseases, Microdeletions, and Aneuploidies Expands Market Opportunities
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Recent Past, Current & Future Analysis for Ultrasound Detection by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 2: World Historic Review for Ultrasound Detection by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 3: World 15-Year Perspective for Ultrasound Detection by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 4: World Recent Past, Current & Future Analysis for Biochemical Screening Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 5: World Historic Review for Biochemical Screening Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 6: World 15-Year Perspective for Biochemical Screening Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 7: World Recent Past, Current & Future Analysis for Cell-free DNA in Maternal Plasma Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 8: World Historic Review for Cell-free DNA in Maternal Plasma Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 9: World 15-Year Perspective for Cell-free DNA in Maternal Plasma Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 10: World Recent Past, Current & Future Analysis for Trisomy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 11: World Historic Review for Trisomy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 12: World 15-Year Perspective for Trisomy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 13: World Recent Past, Current & Future Analysis for Microdeletion Syndrome by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 14: World Historic Review for Microdeletion Syndrome by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 15: World 15-Year Perspective for Microdeletion Syndrome by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 16: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 17: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 18: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 19: World Recent Past, Current & Future Analysis for Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 20: World Historic Review for Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 21: World 15-Year Perspective for Diagnostic Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 22: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 23: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 24: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 25: World Non-Invasive Prenatal Testing (NIPT) Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Non-Invasive Prenatal Testing (NIPT) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Consumables & Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Consumables & Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Consumables & Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Non-Invasive Prenatal Testing (NIPT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 35: USA Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 36: USA Historic Review for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 37: USA 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Method - Percentage Breakdown of Value Sales for Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests for the Years 2015, 2025 & 2030
  • TABLE 38: USA Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 39: USA Historic Review for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 40: USA 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Application - Percentage Breakdown of Value Sales for Trisomy, Microdeletion Syndrome and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 41: USA Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 42: USA Historic Review for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 43: USA 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 44: USA Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 45: USA Historic Review for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 46: USA 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Product - Percentage Breakdown of Value Sales for Consumables & Reagents and Instruments for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 47: Canada Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: Canada Historic Review for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 49: Canada 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Method - Percentage Breakdown of Value Sales for Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests for the Years 2015, 2025 & 2030
  • TABLE 50: Canada Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Canada Historic Review for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 52: Canada 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Application - Percentage Breakdown of Value Sales for Trisomy, Microdeletion Syndrome and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 53: Canada Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Canada Historic Review for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 55: Canada 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 56: Canada Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Canada Historic Review for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 58: Canada 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Product - Percentage Breakdown of Value Sales for Consumables & Reagents and Instruments for the Years 2015, 2025 & 2030
• JAPAN
  • Non-Invasive Prenatal Testing (NIPT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 59: Japan Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Japan Historic Review for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 61: Japan 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Method - Percentage Breakdown of Value Sales for Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests for the Years 2015, 2025 & 2030
  • TABLE 62: Japan Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Japan Historic Review for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 64: Japan 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Application - Percentage Breakdown of Value Sales for Trisomy, Microdeletion Syndrome and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 65: Japan Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Japan Historic Review for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 67: Japan 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 68: Japan Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Japan Historic Review for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 70: Japan 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Product - Percentage Breakdown of Value Sales for Consumables & Reagents and Instruments for the Years 2015, 2025 & 2030
• CHINA
  • Non-Invasive Prenatal Testing (NIPT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 71: China Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: China Historic Review for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 73: China 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Method - Percentage Breakdown of Value Sales for Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests for the Years 2015, 2025 & 2030
  • TABLE 74: China Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: China Historic Review for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 76: China 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Application - Percentage Breakdown of Value Sales for Trisomy, Microdeletion Syndrome and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 77: China Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: China Historic Review for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 79: China 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 80: China Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: China Historic Review for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 82: China 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Product - Percentage Breakdown of Value Sales for Consumables & Reagents and Instruments for the Years 2015, 2025 & 2030
• EUROPE
  • Non-Invasive Prenatal Testing (NIPT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 83: Europe Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Europe Historic Review for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 85: Europe 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Method - Percentage Breakdown of Value Sales for Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests for the Years 2015, 2025 & 2030
  • TABLE 86: Europe Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Europe Historic Review for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 88: Europe 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Application - Percentage Breakdown of Value Sales for Trisomy, Microdeletion Syndrome and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 89: Europe Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Europe Historic Review for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 91: Europe 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 92: Europe Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 93: Europe Historic Review for Non-Invasive Prenatal Testing (NIPT) by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 94: Europe 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 95: Europe Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Europe Historic Review for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 97: Europe 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Product - Percentage Breakdown of Value Sales for Consumables & Reagents and Instruments for the Years 2015, 2025 & 2030
• FRANCE
  • Non-Invasive Prenatal Testing (NIPT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 98: France Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: France Historic Review for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 100: France 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Method - Percentage Breakdown of Value Sales for Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests for the Years 2015, 2025 & 2030
  • TABLE 101: France Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: France Historic Review for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 103: France 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Application - Percentage Breakdown of Value Sales for Trisomy, Microdeletion Syndrome and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 104: France Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: France Historic Review for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 106: France 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 107: France Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: France Historic Review for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 109: France 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Product - Percentage Breakdown of Value Sales for Consumables & Reagents and Instruments for the Years 2015, 2025 & 2030
• GERMANY
  • Non-Invasive Prenatal Testing (NIPT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 110: Germany Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Germany Historic Review for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 112: Germany 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Method - Percentage Breakdown of Value Sales for Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests for the Years 2015, 2025 & 2030
  • TABLE 113: Germany Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Germany Historic Review for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 115: Germany 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Application - Percentage Breakdown of Value Sales for Trisomy, Microdeletion Syndrome and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 116: Germany Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Germany Historic Review for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 118: Germany 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 119: Germany Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Germany Historic Review for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 121: Germany 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Product - Percentage Breakdown of Value Sales for Consumables & Reagents and Instruments for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 122: Italy Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Italy Historic Review for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 124: Italy 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Method - Percentage Breakdown of Value Sales for Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests for the Years 2015, 2025 & 2030
  • TABLE 125: Italy Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Italy Historic Review for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 127: Italy 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Application - Percentage Breakdown of Value Sales for Trisomy, Microdeletion Syndrome and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 128: Italy Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Italy Historic Review for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 130: Italy 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 131: Italy Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Italy Historic Review for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 133: Italy 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Product - Percentage Breakdown of Value Sales for Consumables & Reagents and Instruments for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Non-Invasive Prenatal Testing (NIPT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 134: UK Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: UK Historic Review for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 136: UK 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Method - Percentage Breakdown of Value Sales for Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests for the Years 2015, 2025 & 2030
  • TABLE 137: UK Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: UK Historic Review for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 139: UK 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Application - Percentage Breakdown of Value Sales for Trisomy, Microdeletion Syndrome and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 140: UK Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: UK Historic Review for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 142: UK 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 143: UK Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: UK Historic Review for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 145: UK 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Product - Percentage Breakdown of Value Sales for Consumables & Reagents and Instruments for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 146: Spain Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Spain Historic Review for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 148: Spain 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Method - Percentage Breakdown of Value Sales for Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests for the Years 2015, 2025 & 2030
  • TABLE 149: Spain Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Spain Historic Review for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 151: Spain 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Application - Percentage Breakdown of Value Sales for Trisomy, Microdeletion Syndrome and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 152: Spain Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Spain Historic Review for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 154: Spain 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 155: Spain Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Spain Historic Review for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 157: Spain 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Product - Percentage Breakdown of Value Sales for Consumables & Reagents and Instruments for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 158: Russia Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Russia Historic Review for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 160: Russia 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Method - Percentage Breakdown of Value Sales for Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests for the Years 2015, 2025 & 2030
  • TABLE 161: Russia Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Russia Historic Review for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 163: Russia 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Application - Percentage Breakdown of Value Sales for Trisomy, Microdeletion Syndrome and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 164: Russia Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Russia Historic Review for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 166: Russia 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 167: Russia Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Russia Historic Review for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 169: Russia 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Product - Percentage Breakdown of Value Sales for Consumables & Reagents and Instruments for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 170: Rest of Europe Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Rest of Europe Historic Review for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 172: Rest of Europe 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Method - Percentage Breakdown of Value Sales for Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests for the Years 2015, 2025 & 2030
  • TABLE 173: Rest of Europe Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Rest of Europe Historic Review for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 175: Rest of Europe 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Application - Percentage Breakdown of Value Sales for Trisomy, Microdeletion Syndrome and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 176: Rest of Europe Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Rest of Europe Historic Review for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 178: Rest of Europe 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 179: Rest of Europe Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Rest of Europe Historic Review for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 181: Rest of Europe 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Product - Percentage Breakdown of Value Sales for Consumables & Reagents and Instruments for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Non-Invasive Prenatal Testing (NIPT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 182: Asia-Pacific Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Asia-Pacific Historic Review for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 184: Asia-Pacific 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Method - Percentage Breakdown of Value Sales for Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests for the Years 2015, 2025 & 2030
  • TABLE 185: Asia-Pacific Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Asia-Pacific Historic Review for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 187: Asia-Pacific 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Application - Percentage Breakdown of Value Sales for Trisomy, Microdeletion Syndrome and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 188: Asia-Pacific Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Asia-Pacific Historic Review for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 190: Asia-Pacific 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 191: Asia-Pacific Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 192: Asia-Pacific Historic Review for Non-Invasive Prenatal Testing (NIPT) by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 193: Asia-Pacific 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 194: Asia-Pacific Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Asia-Pacific Historic Review for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 196: Asia-Pacific 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Product - Percentage Breakdown of Value Sales for Consumables & Reagents and Instruments for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Non-Invasive Prenatal Testing (NIPT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 197: Australia Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Australia Historic Review for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 199: Australia 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Method - Percentage Breakdown of Value Sales for Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests for the Years 2015, 2025 & 2030
  • TABLE 200: Australia Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Australia Historic Review for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 202: Australia 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Application - Percentage Breakdown of Value Sales for Trisomy, Microdeletion Syndrome and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 203: Australia Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Australia Historic Review for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 205: Australia 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 206: Australia Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Australia Historic Review for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 208: Australia 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Product - Percentage Breakdown of Value Sales for Consumables & Reagents and Instruments for the Years 2015, 2025 & 2030
• INDIA
  • Non-Invasive Prenatal Testing (NIPT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 209: India Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: India Historic Review for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 211: India 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Method - Percentage Breakdown of Value Sales for Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests for the Years 2015, 2025 & 2030
  • TABLE 212: India Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: India Historic Review for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 214: India 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Application - Percentage Breakdown of Value Sales for Trisomy, Microdeletion Syndrome and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 215: India Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: India Historic Review for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 217: India 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 218: India Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: India Historic Review for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 220: India 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Product - Percentage Breakdown of Value Sales for Consumables & Reagents and Instruments for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 221: South Korea Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: South Korea Historic Review for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 223: South Korea 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Method - Percentage Breakdown of Value Sales for Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests for the Years 2015, 2025 & 2030
  • TABLE 224: South Korea Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: South Korea Historic Review for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 226: South Korea 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Application - Percentage Breakdown of Value Sales for Trisomy, Microdeletion Syndrome and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 227: South Korea Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: South Korea Historic Review for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 229: South Korea 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 230: South Korea Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: South Korea Historic Review for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 232: South Korea 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Product - Percentage Breakdown of Value Sales for Consumables & Reagents and Instruments for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 233: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Rest of Asia-Pacific Historic Review for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 235: Rest of Asia-Pacific 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Method - Percentage Breakdown of Value Sales for Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests for the Years 2015, 2025 & 2030
  • TABLE 236: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Rest of Asia-Pacific Historic Review for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 238: Rest of Asia-Pacific 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Application - Percentage Breakdown of Value Sales for Trisomy, Microdeletion Syndrome and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 239: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Rest of Asia-Pacific Historic Review for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 241: Rest of Asia-Pacific 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 242: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Rest of Asia-Pacific Historic Review for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 244: Rest of Asia-Pacific 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Product - Percentage Breakdown of Value Sales for Consumables & Reagents and Instruments for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Non-Invasive Prenatal Testing (NIPT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 245: Latin America Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Latin America Historic Review for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 247: Latin America 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Method - Percentage Breakdown of Value Sales for Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests for the Years 2015, 2025 & 2030
  • TABLE 248: Latin America Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Latin America Historic Review for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 250: Latin America 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Application - Percentage Breakdown of Value Sales for Trisomy, Microdeletion Syndrome and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 251: Latin America Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Latin America Historic Review for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 253: Latin America 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 254: Latin America Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 255: Latin America Historic Review for Non-Invasive Prenatal Testing (NIPT) by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 256: Latin America 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 257: Latin America Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Latin America Historic Review for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 259: Latin America 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Product - Percentage Breakdown of Value Sales for Consumables & Reagents and Instruments for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 260: Argentina Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Argentina Historic Review for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 262: Argentina 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Method - Percentage Breakdown of Value Sales for Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests for the Years 2015, 2025 & 2030
  • TABLE 263: Argentina Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Argentina Historic Review for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 265: Argentina 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Application - Percentage Breakdown of Value Sales for Trisomy, Microdeletion Syndrome and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 266: Argentina Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Argentina Historic Review for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 268: Argentina 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 269: Argentina Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Argentina Historic Review for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 271: Argentina 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Product - Percentage Breakdown of Value Sales for Consumables & Reagents and Instruments for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 272: Brazil Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Brazil Historic Review for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 274: Brazil 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Method - Percentage Breakdown of Value Sales for Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests for the Years 2015, 2025 & 2030
  • TABLE 275: Brazil Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Brazil Historic Review for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 277: Brazil 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Application - Percentage Breakdown of Value Sales for Trisomy, Microdeletion Syndrome and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 278: Brazil Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Brazil Historic Review for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 280: Brazil 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 281: Brazil Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Brazil Historic Review for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 283: Brazil 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Product - Percentage Breakdown of Value Sales for Consumables & Reagents and Instruments for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 284: Mexico Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Mexico Historic Review for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 286: Mexico 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Method - Percentage Breakdown of Value Sales for Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests for the Years 2015, 2025 & 2030
  • TABLE 287: Mexico Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Mexico Historic Review for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 289: Mexico 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Application - Percentage Breakdown of Value Sales for Trisomy, Microdeletion Syndrome and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 290: Mexico Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Mexico Historic Review for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 292: Mexico 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 293: Mexico Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Mexico Historic Review for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 295: Mexico 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Product - Percentage Breakdown of Value Sales for Consumables & Reagents and Instruments for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 296: Rest of Latin America Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Rest of Latin America Historic Review for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 298: Rest of Latin America 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Method - Percentage Breakdown of Value Sales for Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests for the Years 2015, 2025 & 2030
  • TABLE 299: Rest of Latin America Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Rest of Latin America Historic Review for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 301: Rest of Latin America 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Application - Percentage Breakdown of Value Sales for Trisomy, Microdeletion Syndrome and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 302: Rest of Latin America Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Rest of Latin America Historic Review for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 304: Rest of Latin America 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 305: Rest of Latin America Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Rest of Latin America Historic Review for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 307: Rest of Latin America 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Product - Percentage Breakdown of Value Sales for Consumables & Reagents and Instruments for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Non-Invasive Prenatal Testing (NIPT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 308: Middle East Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Middle East Historic Review for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 310: Middle East 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Method - Percentage Breakdown of Value Sales for Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests for the Years 2015, 2025 & 2030
  • TABLE 311: Middle East Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Middle East Historic Review for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 313: Middle East 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Application - Percentage Breakdown of Value Sales for Trisomy, Microdeletion Syndrome and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 314: Middle East Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 315: Middle East Historic Review for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 316: Middle East 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 317: Middle East Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 318: Middle East Historic Review for Non-Invasive Prenatal Testing (NIPT) by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 319: Middle East 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 320: Middle East Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 321: Middle East Historic Review for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 322: Middle East 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Product - Percentage Breakdown of Value Sales for Consumables & Reagents and Instruments for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 323: Iran Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 324: Iran Historic Review for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 325: Iran 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Method - Percentage Breakdown of Value Sales for Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests for the Years 2015, 2025 & 2030
  • TABLE 326: Iran Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 327: Iran Historic Review for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 328: Iran 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Application - Percentage Breakdown of Value Sales for Trisomy, Microdeletion Syndrome and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 329: Iran Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 330: Iran Historic Review for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 331: Iran 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 332: Iran Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 333: Iran Historic Review for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 334: Iran 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Product - Percentage Breakdown of Value Sales for Consumables & Reagents and Instruments for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 335: Israel Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 336: Israel Historic Review for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 337: Israel 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Method - Percentage Breakdown of Value Sales for Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests for the Years 2015, 2025 & 2030
  • TABLE 338: Israel Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 339: Israel Historic Review for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 340: Israel 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Application - Percentage Breakdown of Value Sales for Trisomy, Microdeletion Syndrome and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 341: Israel Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 342: Israel Historic Review for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 343: Israel 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 344: Israel Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 345: Israel Historic Review for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 346: Israel 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Product - Percentage Breakdown of Value Sales for Consumables & Reagents and Instruments for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 347: Saudi Arabia Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 348: Saudi Arabia Historic Review for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 349: Saudi Arabia 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Method - Percentage Breakdown of Value Sales for Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests for the Years 2015, 2025 & 2030
  • TABLE 350: Saudi Arabia Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 351: Saudi Arabia Historic Review for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 352: Saudi Arabia 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Application - Percentage Breakdown of Value Sales for Trisomy, Microdeletion Syndrome and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 353: Saudi Arabia Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 354: Saudi Arabia Historic Review for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 355: Saudi Arabia 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 356: Saudi Arabia Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 357: Saudi Arabia Historic Review for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 358: Saudi Arabia 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Product - Percentage Breakdown of Value Sales for Consumables & Reagents and Instruments for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 359: UAE Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 360: UAE Historic Review for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 361: UAE 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Method - Percentage Breakdown of Value Sales for Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests for the Years 2015, 2025 & 2030
  • TABLE 362: UAE Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 363: UAE Historic Review for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 364: UAE 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Application - Percentage Breakdown of Value Sales for Trisomy, Microdeletion Syndrome and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 365: UAE Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 366: UAE Historic Review for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 367: UAE 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 368: UAE Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 369: UAE Historic Review for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 370: UAE 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Product - Percentage Breakdown of Value Sales for Consumables & Reagents and Instruments for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 371: Rest of Middle East Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 372: Rest of Middle East Historic Review for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 373: Rest of Middle East 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Method - Percentage Breakdown of Value Sales for Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests for the Years 2015, 2025 & 2030
  • TABLE 374: Rest of Middle East Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 375: Rest of Middle East Historic Review for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 376: Rest of Middle East 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Application - Percentage Breakdown of Value Sales for Trisomy, Microdeletion Syndrome and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 377: Rest of Middle East Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 378: Rest of Middle East Historic Review for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 379: Rest of Middle East 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 380: Rest of Middle East Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 381: Rest of Middle East Historic Review for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 382: Rest of Middle East 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Product - Percentage Breakdown of Value Sales for Consumables & Reagents and Instruments for the Years 2015, 2025 & 2030
• AFRICA
  • Non-Invasive Prenatal Testing (NIPT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 383: Africa Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 384: Africa Historic Review for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 385: Africa 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Method - Percentage Breakdown of Value Sales for Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests for the Years 2015, 2025 & 2030
  • TABLE 386: Africa Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 387: Africa Historic Review for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 388: Africa 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Application - Percentage Breakdown of Value Sales for Trisomy, Microdeletion Syndrome and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 389: Africa Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 390: Africa Historic Review for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 391: Africa 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 392: Africa Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 393: Africa Historic Review for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 394: Africa 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Product - Percentage Breakdown of Value Sales for Consumables & Reagents and Instruments for the Years 2015, 2025 & 2030

IV. COMPETITION